**To the Editor:** Studies conducted in Malaysia have raised questions about *Plasmodium knowlesi* as the fifth human pathogenic malaria parasite ([@R1],[@R2]); additional cases of *P. knowlesi* malaria have subsequently been reported from other Asian countries ([@R3]--[@R5]). Microscopic diagnosis is hindered because *P. knowlesi* morphologically resembles *P. falciparum* or *P. malariae*, depending on blood stage ([@R6]). Singh et al. has designed a nested PCR assay for identification of *P. knowlesi* infections ([@R1]).

As part of an ongoing research project focusing on characterizing genes from malaria isolates in Indonesia (E. Sulistyanisih, unpub. data), during December 2008--February 2009, blood samples from 22 gold miners with uncomplicated malaria were collected in South Kalimantan Province in Indonesia. Ring forms typical for *P. falciparum* were seen during microscopy. DNA was extracted and species were identified by nested PCR by using *Plasmodium* genus- and species-specific primers derived from the small subunit ribosomal RNA gene described elsewhere ([@R1]). PCR products were directly sequenced and verified by 2 independent amplifications of the same DNA sample. PCR using *P. knowlesi*--specific primers yielded a 153-bp product in samples from 4 of the 22 malaria cases. Sequencing showed perfect matching with the recently published *P. knowlesi* S-type from Malaysian Borneo for 1 of the 4 samples. The other sequences were repeatedly consistent with the small subunit ribosomal RNA gene of sporozoite *P. vivax* (S-type), and random blasting (<http://blast.ncbi.nlm.nih.gov>) showed higher homology (93%--100%) with various *P. vivax* strains than with different *P. knowlesi* (\<84%) or other *Plasmodium* strains. The vivax-specific PCR showed the expected bands in each case, and sequencing confirmed *P. vivax* A-type DNA that matched perfectly with a strain from Thailand. Of the miners with malaria, 3 case-patients were coinfected with *P. falciparum*. All 22 samples from the case-patients were negative for *P. malariae*. One case-patient (P 15) infected with *P. knowlesi* (4,000 parasite ring forms/μL) had a mixed infection with *P. vivax* and was successfully treated with chloroquine-primaquine ([Table](#T1){ref-type="table"}).

###### Profile of *Plasmodium knowlesi*--positive patients, South Kalimantan Province, Indonesia, December 2008--February 2009**\***

  Patient no.   Age, y   Microscopy-based diagnosis   PCR-based diagnosis                      *P. knowlesi*--specific PCR for quality of 153-bp band   Sequence analysis of 153-bp sequence
  ------------- -------- ---------------------------- ---------------------------------------- -------------------------------------------------------- --------------------------------------
  8             35       *P. falciparum*              *P. falciparum, P. vivax, P. knowlesi*   Strong                                                   *P. vivax*
  9             41       *P. falciparum*              *P. falciparum, P. vivax, P. knowlesi*   Strong                                                   *P. vivax*
  14            54       *P. falciparum*              *P. falciparum, P. vivax, P. knowlesi*   Weak                                                     *P. vivax*
  15            16       *P. falciparum*              *P. knowlesi, P. vivax*                  Weak                                                     *P. knowlesi* (GU233448)†

\*All patients were men who received a diagnosis of uncomplicated malaria. †GenBank accession number.

The results of this study indicate the geographic distribution of natural *P. knowlesi* human infections includes Indonesian Borneo, although this detection is no surprise because many *P. knowlesi* isolates are found in Malaysian Borneo ([@R1]*,*[@R2])*.* However, the diagnosis would have been unrecognized without molecular techniques, and even those techniques posed a problem.

The species-specific nested PCR assay repeatedly showed bands of 153 bp, indicating 4 *P. knowlesi* cases, but sequencing confirmed *P. knowlesi* in only 1 sample. There was no indication of contamination of the samples tested by PCR, and the other 18 samples and the negative control remained negative for *P. knowlesi*. All 3 samples showed molecularly confirmed mixed infections with *P. falciparum* and *P. vivax* in the case-patients. As *P. vivax* was only molecularly detected, low parasitemia was assumed.

The reverse primer sequence (pmkr 9) is found in *P. vivax* S-type strains and other *Plasmodium* spp., especially those related to *P. vivax*, thus, amplification from this site should be theoretically possible. The forward primer pmk 8, on the other hand, seemed to be highly specific.

One *Plasmodium* strain (GenBank accession no. DQ660817) found in orangutans in Kalimantan, Indonesia, and classified as *P. vivax,* seemed to be more likely to bind to pmk 8 ([@R7]). However, this classification was recently disproved by Singh and Divis ([@R8]), and the parasite was categorized as probably being *P. pitheci* or *P. silvaticum*, where human infections are not described. Other primate malaria parasites, such as *P. hylobati*, *P. inui*, *P. cynomolgi*, *P. simium*, *P. fieldi*, and *P. simiovale*, showed better binding sites for pmk 8 than *P. vivax* S- or A-strains. Regarding the theory of *P. vivax* originating in macaques in Southeast Asia and the close relationship to other primate malaria parasites ([@R9]), one might imagine that *P. vivax* strains in Indonesia differ slightly from the strains described so far. A *P. vivax* isolate from Indonesia, recently sequenced in cooperation with the University of Heidelberg (GenBank accession no. GU233452), showed 2 point mutations; the patient had been in Flores, Bali, and Lembata. However, the 3 *P. vivax* samples presented no mutations at the pmk 8 binding sites. Notably, pmk 8 and pmkr 9 seem always to amplify the S-type and the rVIV 1 and rVIV 2 primers, the A-type DNA, respectively. The genus-specific DNA amplified both types at random.

Some colleagues have experienced similar difficulties with the primers pmk 8 and pmkr 9 in samples from Vietnam ([@R5]); 2 of 5 samples gave false positive results for *P. knowlesi*. Unfortunately, their report did not mention which species was actually amplified ([@R5]).

Until recently, we had no satisfying explanation for the 3 assumed false-positive results. Then, in 2009, Imwong et al. reported that these *P. knowlesi* primers stochastically cross-react with *P. vivax* genomic DNA. No polymorphisms alleviating the binding of pmk8 were found; however, a new PCR for *P. knowlesi* was introduced ([@R10]).

Given the large distribution of the vector and the natural host of *P. knowlesi* in Southeast Asia, it is likely that *P. knowlesi* will be found in other parts of Indonesia. As microscopic and molecular diagnosis of this parasite seems difficult, the underestimation of its distribution and clinical relevance can be assumed.
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